Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.640
+0.147 (9.85%)
At close: Jul 31, 2026, 4:00 PM EDT
1.700
+0.060 (3.66%)
Pre-market: Aug 3, 2026, 5:56 AM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $1.99 million as of August 3, 2026. Its market cap has decreased by -92.06% in one year.
Market Cap
1.99M
Enterprise Value
-2.38M
1-Year Change
-92.06%
Ranking
Category
Stock Price
$1.64
ChartMarket Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.83M to $1.99M, a decrease of -99.27%. That is a compound annual growth rate of -64.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.99M | -76.70% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.45M | -64.38% |
| Dec 30, 2021 | 282.03M | 3.00% |
| Nov 1, 2021 | 273.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearmind Medicine | 2.51M |
| Creative Medical Technology Holdings | 2.45M |
| GRI Bio | 2.44M |
| Propanc Biopharma | 2.30M |
| Oragenics | 2.26M |
| Decoy Therapeutics | 2.19M |
| Azitra | 2.15M |
| Moleculin Biotech | 2.13M |